Everolimus (Rolimus) Tablets

  • Medicine Name- Rolimus
  • API- Everolimus
  • Packaging- 10 Tablets
  • Strength- 5 mg, 10 mg
  • Manufactured by- Cipla Ltd
Get an Enquiry

Description

Everolimus is a kinase inhibitor used for the treatment of:

  • Postmenopausal women with advanced HR-positive, HER2­-negative breast cancer together with exemestane after failure of treatment with letrozole or anastrozole.
  • Adult patients with progressive neuroendocrine tumors of pancreatic origin (PNET) and adult patients with progressive, well-differentiated, non-functional neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin that are unresectable, locally advanced or metastatic. 
  • Adult patients diagnosed with advanced renal cell carcinoma (RCC) who have not responded to prior treatment with sunitinib or sorafenib.
  • Adult patients diagnosed with renal angiomyolipoma and tuberous sclerosis complex (TSC), who do not currently need immediate surgical intervention.

FAQ’s

What is Everolimus?

Everolimus is a medication used to treat various types of cancers, including breast cancer, kidney cancer, and certain types of tumors in the pancreas or gastrointestinal tract. 

How should I take Everolimus? 

Take Everolimus exactly as prescribed by your doctor, usually once daily, with or without food, and swallow the tablet whole.

How can I store Everolimus?

Store Everolimus at room temperature, away from moisture and heat, in its original container, and keep it out of reach of children.

How much does Everolimus cost in India?

Everolimus cost in India is reasonable and can vary. To procure this therapeutic drug legally, you can call us at (+91) 8130290915, TOLL-FREE: 1800-889-1064, Or Write us at info@indiangenericmedicines.com.

Can Everolimus be used while I’m pregnant?

Consult your doctor regarding the safest approach to managing your condition if you plan to conceive or are pregnant, as Everolimus may pose risks.

Can Everolimus be used while breastfeeding?

Avoid breastfeeding while taking Everolimus. Discuss with your doctor if you are currently breastfeeding or planning to breastfeed in the future.

Where can I get Everolimus at the best Price? 

Order Everolimus at the best price today. We request you to Call/WhatsApp us at (+91) 8130290915 or dial our TOLL-FREE Number: 1800-889-1064 or Write us at info@indiangenericmedicines.com. We are fully committed to providing you with the best Everolimus price from India. That is why we’ll match the cost/price of any other existing suppliers/distributors in the market who require a medical prescription.

Is Everolimus available in India?

Everolimus is a (prescription drug, doctor-prescribed medication, or health care professional-prescribed medicine) pharmaceutical drug that can be legally dispensed against a medical prescription. Everolimus can be made available through the network of authorized distributors in India. (Mumbai, Ahmedabad, Kolkata, Hyderabad, Bangalore, Chennai, Delhi, Pune, etc.)

Can You Send the Everolimus to Foreign Destinations?

Buy generic Everolimus online at the best/lowest price from a leading supplier. Indian Generic Medicines (IGM) can assist in the delivery of Everolimus; the doctor-prescribed medication to the UK, Canada, UAE, Saudi Arabia, Australia, Philippines, the USA, Thailand, China, South Africa, Kazakhstan, Uzbekistan, Hong Kong, Malaysia, Zambia, Pakistan, Sri Lanka, Sweden, Turkey, Afghanistan, Singapore, Japan, Qatar, Nepal, Kuwait, and many other countries.

What is the procedure to buy Everolimus from Indian Generic Medicines

Patients can fill out the order form or send mail to info@indiangenericmedicines.com. Patients can also send WhatsApp messages to +91 8130290915 or can dial the TOLL-FREE Number: 18008891064. We will reply ASAP with the details of the Everolimus 5 mg/10 mg price and the procurement procedure.

Note:- The order will be confirmed only after the valid receipt of the prescription from the Physician.

Is it safe to buy Everolimus online from India?

Yes, one can buy Everolimus online from India-based Indian Generic Medicines if the medicine is not (yet) registered or is unavailable in their respective country. We can facilitate the supply of Everolimus tablets through legal channels.

Dosage and Side Effects

The recommended dosage of Everolimus for patients with HR-positive, HER2­-negative breast cancer, PNET, renal cell carcinoma (RCC), and tuberous sclerosis complex (TSC) is 10 mg orally once daily until disease progression or unacceptable toxicity. Take Everolimus tablets by swallowing them whole with a glass of water. It is not advisable to break or crush tablets. 

The most common side effects of Everolimus in patients with Breast cancer, NET, and RCC are abdominal pain, fever, rash, infections, fatigue, diarrhea, edema, nausea, stomatitis, asthenia, cough, headache, and decreased appetite. 

The most common side effect of Everolimus in patients with TSC-associated renal Angiomyolipoma is stomatitis.

Warning and Precautions

  • Non-infectious pneumonitis may occur in patients treated with Everolimus. Consider a diagnosis of non-infectious pneumonitis in individuals presenting with non-specific respiratory symptoms. Be mindful of opportunistic infections like pneumocystis jiroveci pneumonia (PJP) when considering potential diagnoses. Patients should report quickly any new or worsening respiratory signs and symptoms. 
  • Everolimus has immunosuppressive properties and may predispose patients to fungal, bacterial, viral, or protozoal infections, including infections with opportunistic pathogens. Complete treatment of preexisting invasive fungal infections before starting treatment. Keep an eye on patients for any indications or signs of infection. Withhold or permanently stop Everolimus based on the severity of the infection.
  • Anemia, lymphopenia, neutropenia, and thrombocytopenia may be reported in patients taking Everolimus. Before beginning Everolimus 5 mg/10 mg treatment, it’s essential to check your complete blood count every six months for the first year, then yearly thereafter. Withhold or permanently stop Everolimus based on severity.
  • Hyperglycemia, hypercholesterolemia, and hypertriglyceridemia may be reported in those taking Everolimus. Monitor lipid profile before starting treatment and later on annually. When possible, achieve optimal glucose and lipid control before starting Everolimus treatment.
  • Everolimus delays wound healing and increases the occurrence of wound-related complications like wound infection, wound dehiscence, lymphocele, incisional hernia, and seroma. These wound-related complications may need surgical intervention. Exercise caution with the use of Everolimus in the peri-surgical period.